Published on: December 05, 2019 at 10:30PM
Condition: Asthma
Interventions: Drug: AZD8154 nebulizer suspension, 20 mg/mL; Drug: Placebo
Sponsors: AstraZeneca; Parexel
Not yet recruiting
https://ift.tt/2LqN58M
Thursday, 5 December 2019
New asthma clinical trial: A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.